Kangstem Biotech selected by ‘F1000Prime’ for its publication about rheumatoid arthritis
Kangstem Biotech announced on the 8th that a paper about ‘Furestem-RA,’a rheumatoid arthritis stem cell treatment being developed by the company, was selected as an excellent paper by ‘Faculty of 1000 Prime(hereinafter referring to F1000Prime),’ a British online paper search system.
F1000Prime s...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
